Unique ID issued by UMIN | UMIN000008760 |
---|---|
Receipt number | R000010290 |
Scientific Title | Comparison between clomiphene citrate plus hMG or hMG alone, combined with flexible multi dose GnRH antagonist for patients with poor prognosis in IVF-ET programs |
Date of disclosure of the study information | 2012/08/24 |
Last modified on | 2014/08/25 20:22:58 |
Comparison between clomiphene citrate plus hMG or hMG alone, combined with flexible multi dose GnRH antagonist for patients with poor prognosis in IVF-ET programs
Clomiphene citrate plus HMG or hMG alone combined with flexible multi dose GnRH antagonist for patients with poor prognosis in IVF-ET programs
Comparison between clomiphene citrate plus hMG or hMG alone, combined with flexible multi dose GnRH antagonist for patients with poor prognosis in IVF-ET programs
Clomiphene citrate plus HMG or hMG alone combined with flexible multi dose GnRH antagonist for patients with poor prognosis in IVF-ET programs
Japan |
Infertile patient and poor responder in controlled ovarian hyperstimulation
Obstetrics and Gynecology |
Others
NO
Compare the pregnancy rate of Clomid-hMG-GnRH antagonist regimen with hMG-GnRH antagonist protocol.
Demonstrate non-inferiority of Clomid regimen.
Bio-equivalence
Confirmatory
Explanatory
Not applicable
Evaluate the clinical pregnancy rate per ovarian stimulation, oocyte retrieval, and embryo transfer.
Interventional
Parallel
Randomized
Cluster
Open -no one is blinded
Active
2
Treatment
Medicine |
hMG-GnRH antagonist: start HMG(FSH:LH 1:1) from day3 until the day of hCG administration. Concomitant treatment with Ganirelix 0.25mg s.c. in multiple, flexible method when leading follicle reaches 14-15mm. HCG 10000IU when leading follicle reaches 18-20mm.
CC-hMG-GnRH antagonist: Clomiphen citrate 100mg/d from day 3 to 7. Start HMG 300IU/d daily from day 8.
Concomitant treatment with GnRH antagonist as above.
HCG administration is the same as above.
Not applicable |
45 | years-old | >= |
Female
1) require IVF-ET for infertility treatment
2) less than four-times-history of controlled ovarian hyper stimulation with GnRH antagonist
3) Exhibit ovarian dysfunction by the findings such as
basal FSH above 10 mIU/ml, antral follicle count below 7, and oocyte retrieval below 5 in the previous cycle.
1) above 46 years of age
2) not allowed to be pregnant due to other medical complications
3) scheduled to undergo freezing of all embryos due to gynecological conditions such as myomas and adenomyosis.
110
1st name | |
Middle name | |
Last name | Akihisa Fujimoto |
Department of Obstetrics and Gynecology
Faculty of Medicine, The University of Tokyo
OBGYN, IVF center
Hongo 7-3-1, Bunkyo-ku, Tokyo
0338155411
fujimoto-tky@umin.ac.jp
1st name | |
Middle name | |
Last name | Hajime Oishi |
The University of Tokyo, Faculty of Medicine
Department of Obstetrics and Gynecology
7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
03-3815-5411(ext.33407)
hooishi-tky@umin.ac.jp
Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo
None
Self funding
NO
2012 | Year | 08 | Month | 24 | Day |
Unpublished
Terminated
2011 | Year | 10 | Month | 25 | Day |
2011 | Year | 12 | Month | 01 | Day |
2013 | Year | 09 | Month | 01 | Day |
2013 | Year | 09 | Month | 01 | Day |
2013 | Year | 09 | Month | 01 | Day |
2014 | Year | 02 | Month | 01 | Day |
2012 | Year | 08 | Month | 23 | Day |
2014 | Year | 08 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010290